Viral Myopericarditis Recurrence Predictor

Clinical calculation support · Verify results before clinical use

Clinical profile

Record patient characteristics and findings relevant to clinical review. This form does not calculate a validated viral myopericarditis recurrence probability.

Clinical review
Patient age at assessment.
Enter 0 if there have been no recurrences.
Enter the measured left ventricular ejection fraction.
CMR late gadolinium enhancement (LGE)
Record the CMR report category. LGE pattern and myocardial versus pericardial involvement should be interpreted in context.
Current therapy at assessment
Medication exposure is recorded for clinical context; these selections do not imply that a therapy causes recurrence or is indicated.

Clinical context and limitations

Myopericarditis describes pericarditis with evidence of myocardial involvement. Recurrence prediction in viral myopericarditis is not interchangeable with prediction of recurrent pericarditis or with models designed to predict remission from recurrent pericarditis.

Why this tool does not calculate a score

  • The Cleveland Clinic model was developed retrospectively in a recurrent pericarditis cohort, not a dedicated viral myopericarditis cohort.
  • Its outcome was long-term clinical remission, defined by symptom resolution and cessation of anti-inflammatory therapy; it should not be relabelled as a validated viral myopericarditis recurrence probability.
  • The original model's weights should not be transferred to a different target population without external validation.

How to use the profile

Use the recorded findings to support, not replace, clinical assessment. Interpret ventricular dysfunction, arrhythmias, ongoing myocardial injury, symptoms, biomarkers, and CMR in the context of the individual patient and current guidance. Treatment choices should be based on diagnosis and guideline-supported indications, not this profile alone.

References

Yesilyaprak A, et al.Predicting Long-Term Clinical Outcomes of Patients With Recurrent Pericarditis. Journal of the American College of Cardiology. 2024;84(13):1193–1204. DOI: 10.1016/j.jacc.2024.05.072. This model is cited to explain the scope limitation, not used to calculate a viral myopericarditis score.
Yesilyaprak A, et al. — PubMed recordAbstract and bibliographic record for the recurrent pericarditis prognostic model. PubMed PMID 39217549.
Clinical evidence statusA dedicated, externally validated recurrence score for viral myopericarditis was not identified in the evidence reviewed for this redesign. This is a bounded literature check, not proof that no such study exists.
Clinical disclaimer: This tool records selected clinical variables and provides no validated recurrence probability, risk category, or treatment recommendation. It is intended for healthcare professionals and must not replace clinical judgement, local protocols, specialist assessment, or current guidelines. The tool has not been prospectively validated.